« Return to News | Technology Solutions

Smith & Nephew and Essex Woodlands share resources to create Bioventus

Friday, January 6, 2012 09:44 AM

Smith & Nephew, a U.K.-based global media technology business, established a joint biologics venture with Essex Woodlands (U.S.), a special healthcare growth equity and venture capital firm headquartered in Durham, N.C. The move will bolster Essex Woodland’s pre-existing biologics and clinical therapies division in Durham, while Smith & Nephew will receive approximately $98 million cash and a $160 million five-year note from the new entity, Bioventus.

With combined resources, Bioventus will be able to focus on longer-term development projects; both parent companies plan to invest a significant portion of Bioventus’s cash flow into R&D over the next five years. Meanwhile, the entity will continue to market its current portfolio of products, such as the EXOGEN Ultrasound Bone Healing System.

“We see tremendous growth potential with this new venture as more patients discover how active products can help heal and treat joint and bone ailments without invasive surgery,” said Marty Sutter, founding partner and managing director of Essex Woodlands.  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.